Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 121 for “"ADMA"”.
-
The role of CaSR signalling in adipocytes and its regulation by ADMA
… by the amino acid asymmetric dimethylarginine (ADMA) via a nitric oxideindependent, CaSR pathway. However, the underpinning mechanisms and relevance in adipocytes was not clearly identified. This thesis aimed to delineate CaSR signalling pathways in vitro, and subsequently test the effect of …
-
Η αξιολόγηση της ADMA (ασυμμετρική διμεθυλαργινίνη) στην προεκλαμψία και στον πρόωρο τοκετό
Asymmetric dimethylarginine (ADMA) is a molecule that occurs when two methyl groups are transferred asymmetrically to the molecule of L-Arginine. It is a marker of endothelial pathology. The purpose of this study is the evaluation of ADMA as a predictive marker in cases of preeclampsia and …
-
Investigating Asymmetric dimethylarginine (ADMA) and Calcium-sensing receptor (CaSR) signalling in the macrophage
… demonstrated that asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, acts as a CaSR ligand in adipocytes, exerting NOS-independent effects. Based on this, it was hypothesised that a similar signalling pathway operates in macrophages, modulating inflammation …
-
The measurement, biological variation and response to acute inflammation of asymmetric dimethylarginine (ADMA)
… and methods Asymmetric dimethylarginine (ADMA) is a potent endogenous competitive inhibitor of nitric oxide synthases, which has attracted considerable attention as a marker and mediator of atherosclerotic disease and as a potential mediator of multiple organ failure in critical illness …
-
Estudio prospectivo de morbimortalidad en pacientes en hemodiálisis crónica: papel de la dimetilarginina asimétrica (ADMA)
… común de muerte. La dimetilarginina asimétrica (ADMA) es un inhibidor endógeno de la óxido nítrico sintasa que puede ser un factor de riesgo independiente para la disfunción endotelial y la enfermedad cardiovascular...
-
ADMA und Homoarginin – Neue kardiovaskuläre Risikomarker und ihre Einflussgrößen in einer Hochrisikokohorte von AICD-Patienten
… Sowohl asymmetrisches Dimethylarginin (ADMA) als auch Homoarginin (hArg) haben Einfluss auf den Stickstoffmonoxid (NO)-Stoffwechsel. HArg scheint die Verfügbarkeit von NO zu erhöhen und wirkt so protektiv auf das Endothel, während AMDA als Inhibitor der NO-Synthase (NOS) fungiert und so …
-
Investigating the roles of the ADMA-DDAH1 pathway in cerebral artery function and ischaemic stroke pathogenesis
… health and disease. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of eNOS and the dimethylarginine dimethylaminohydrolase (DDAH) 1 and 2 enzymes regulate ADMA levels. Several studies have shown that ADMA levels are elevated following ischaemic stroke and that loss-of-function DDAH1 …
-
Μελέτη αξιολόγησης της ADMA (ασυμμετρικής διμεθυλαργινίνης) ως πρώιμου δείκτη ενδοθηλιοπάθειας στην προεκλαμψία και στον πρόωρο τοκετό
… υπέρτασης.Η κύρια αιτία των αυξημένων επιπέδων ADMA στα περιστατικά προεκλαμψίας είναι ακόμη υπό διερεύνηση. Υπάρχουν πολλές θεωρίες και ισχυρισμοί σχετικά με τους πιθανούς μηχανισμούς αύξησης των επιπέδων ADMA στην προεκλαμψία όπως η ισχαιμία του πλακούντα και η επαναιμάτωσή του με το …
-
The Characteristics Of Soft Tissue Following Root Coverage Procedures With Two Types Of Acellular Dermal Matrix Allografts
Acellular dermal matrix allograft (ADMA) has emerged as a reliable substitute for autogenous soft tissue grafts in the treatment of gingival recessions and lack of keratinized gingiva (KG). ADMA has been hypothesized to create a zone of "immobile tissue" extending apical to the mucogingival …
-
Die Aussagekraft des asymmetrischen Dimethylarginins für das renale Outcome bei Kontrastmittelgabe anhand einer prospektiven klinischen Studie
Einleitung: Asymmetrisches Dimethylarginin (ADMA) ist ein kompetitiver Inhibitor der Stickstoffmonoxid-Synthase und ein wichtiger Faktor in der Gefäßregulation. Es wird durch posttranslationale Modifikation von Proteinen gebildet und durch Proteolyse im Körper freigesetzt. In der Literatur wurde …
-
Evaluation of the diagnostic value of asymmetric dimethylarginine for use as cardiac biomarker in horses and its assessment in endurance horses competing at 160 km
Asymmetric dimethylarginine (ADMA) is a well-established cardiac biomarker in humans. The purpose of this prospective study was to investigate if measuring serum ADMA concentration via ELISA allows detection of cardiac disease in horses. In this context, ADMA reference values in horses were …
-
Hemmung der Mobilisation und Funktion humaner endothelialer Vorläuferzellen durch den endogenen NO-Synthase-Inhibitor asymmetrisches Dimethylarginin (ADMA) bei koronarer Herzkrankheit
… eNOS-Inhibitors asymmetrisches Dimethylarginin (ADMA) im Plasma mit zunehmender Schwere der KHK erhöhte (0,47 ± 0,02 μmol/l bei fehlender KHK gegenüber 0,58 ± 0,02 μmol/l bei koronarer 3-Gefäßerkrankung). ADMA ist über eine Hemmung der eNOS an der Entstehung und Aufrechterhaltung einer …
-
Ο ρόλος της ασύμμετρης διμεθυλαργινίνης (ADMA) στην παθογένεια της νεφρικής ανεπάρκειας σε ασθενείς με αυτοσωματική επικρατούσα πολυκυστική νόσο νεφρών (ΑΕΠΚΝ)
… years around the methylarginines and especially ADMA. It is an endogenous inhibitor of the NO synthases and impairs endothelium-dependent vasodilation.There are a large number of data linking ADMA with proteinuria and hypertension, which are classical CKD progression factors. There are also …
-
Εκτίμηση παραγόντων καρδιαγγειακού κινδύνου σε παιδιά και εφήβους με δυσλιπιδαιμία
… dysfunction. Asymmetric dimethylarginine (ADMA) and lipoprotein associated phospholipase A2 (Lp-PLA2) are considered markers of early atherosclerosis and predictors of late complications in adulthood. Aim: To establish the relationship between ADMA, Lp-PLA2 and traditional cardiovascular …
-
Investigating the effects of asymmetric dimethylarginine in the microcirculation
… such as asymmetric dimethylarginine (ADMA), reduce NO bioavailability by inhibiting endothelial NO synthase (NOS), and elevated plasma ADMA concentration is a strong predictor of cardiovascular disease and mortality. Despite the clinical importance, our understanding of the roles of …
-
Characterization of tissue expression and activity of human alanine:glyoxylate aminotransferase 2
… methylarginines, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) as wells as the enzymes, which are involved in their catabolism, dimethyarginine dimethylaminohydrolases (DDAHs) and alanine:glyoxylate aminotransferase 2 (AGXT2) in the pathogenesis of metabolic syndrome …
-
The influence of selected biological, lifestyle risk factors and fitness on plasma Hcy and ADMA concentrations and vascular function : the AGAHL–study
… (Hcy) and asymmetric dimethylarginine (ADMA) are two of these newly identified risk factors for CVD. They need to be studied in order to understand the underlying mechanisms involved in endothelial function, inflammation and arterial properties. The objective of this study was to …
-
The law and practice of healthcare decision-making for adults with severe to profound intellectual disabilities
… Decision-Making (Capacity) Act 2015 (“the ADMA”). It addresses three related research questions. The first research question interrogates the legal and international human rights background that affects healthcare decision-making by and for adults with severe to profound ID. The second …
-
Wirkung von Rosiglitazon im Tiermodell des ischämischen akuten Nierenversagens
… „Asymmetrisches Dimethylarginin“ (ADMA), das eNOS kompetitiv hemmt, stieg im iANV in der Clamp+NaCl und in der Clamp+RGZ Gruppe um ungefähr 20% an. Das an der Synthese von ADMA beteiligte Enzym PRMT 1 (Proteinargininmethyltransferase) und das ADMA-abbauende Enzym DDAH II …
Page 1 of 7